Beneficient cash flow to debt ratio of -40.00% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Beneficient's free cash flow has increased -0.22% from $-38.80M last year to $-38.72M, signaling increasing performance

Beneficient's debt to equity ratio is 1.07, which means that the company's assets are unhealthy financed, signaling financial risk.

Beneficient's debt has increased relative to shareholder equity from -0.71 last year to 1.07 today, signaling weakened financials

Beneficient has negative EBITDA, making leverage ratio unreliable

Beneficient's interest coverage ratio is -5.55, which means that the company struggles to meet interest obligations, signaling financial risk.

Beneficient's profit margin has increased (-123.57%) in the last year from -643.95% to 151.79%, signaling increasing performance

Beneficient's short-term liabilities of $239.14M exceed its short-term assets of $2.54M, signaling financial risk

Beneficient's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Beneficient's return on equity of 65.74%, is higher than 15.00%, indicating good performance

Beneficient's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Beneficient has insufficient public price history to evaluate earnings stability.

Beneficient has negative free cash flow, indicating the company is burning cash rather than generating it

Beneficient has negative free cash flow, indicating cash burn

Beneficient's yearly earnings has decreased 270.88% since last year from $51.16M to $-87.43M, signaling decreasing performance

Beneficient's yearly revenue has decreased 392.45% since last year from $-7.95M to $-39.12M, signaling decreasing performance

ROIC 31.65% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Beneficient has insufficient revenue history to calculate 3-year revenue CAGR.

Beneficient has insufficient revenue history to evaluate consistency.

Beneficient has insufficient public price history to evaluate ROE consistency.

Beneficient has insufficient data to evaluate this check.

Beneficient has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Beneficient is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Beneficient has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Beneficient has insufficient data to evaluate this check.

Beneficient has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Beneficient has negative shareholder equity; price-to-book is not meaningful and the check fails

Beneficient has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue